Denali Advisors sells stake in Exactech: 5 notes

During the fourth quarter, Denali Advisors sold its stake in Exactech, according to EMQ News & Analysis.

Advertisement

Here are five notes:

 

1. Denali Advisors previously held 100 shares in Exactech, for a total value of $1,862.

 

2. On Jan. 28, Exactech shares reached $18.62, up nearly 1.1 percent.

 

3. The company’s 50-day moving average is $18.22 and 200-day moving average is $18.41.

 

4. The market cap is $262.13 million and P/E ratio is 16.64.

 

5. Exactech has a one-year high of $26.20 and one-year low of $16.11. 

 

More article on devices:
Loma Linda University health clinic 1st in state to implant St. Jude Medical Invisible Trial System: 4 things to know
Global orthopedic trauma devices market to reach $9.4B by 2020: 5 key trends
Global orthopedic trauma devices market to reach $9.4B by 2020: 5 key trends

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.